Drontal Oral Suspension for Puppies 50ml

What is the active ingredient in Drontal?

The active ingredients in DRONTAL® Oral Suspension for Puppies are pyrantel, which causes spastic paralysis of the parasite and allows it to be expelled by the gastrointestinal (GI) system using peristalsis, and febantel, which causes disruption to the metabolic processes of the parasite, resulting in death when its energy reserves are exhausted.

What does this ingredient do?

In this fixed combinationthe pyrantel and febantel act synergistically against nematodes (ascarids, hookworms and whipworms) of dogs. In particular, the spectrum of activity covers Toxocara canis, Ancyclostoma caninum and Trichuris vulpis. Published data are also available to confirm that Toxascaris leonina and Uncinaria stenocephala are also susceptible to this particular combination.

What is in Drontal?

Each ml contains:

Active substances:

Febantel 15.00mg
Pyrantel 5.00mg (as pyrantel embonate 14.40mg)

Excipients:

Sodium benzoate (E211) 2.05mg
Sodium propionate (E281) 2.05mg
Ponceau 4R (E124) 0.25mg

Sodium dihydrogen phosphate dihydrate
Sorbitan oleate (E494)
Povidone K25 (E1202)
Polysorbate 80 (E433)
Docusate sodium
Bentonite (E558)
Citric acid anhydrous (E330)
Xanthan gum (E415)
Propylene glycol (E1520)
Purified water

How do I use Drontal?

The recommended dose rates for puppies and young dogs up to one year of age are:

For a single oral administration, 15 mg/kg bodyweight febantel and 5 mg/kg bodyweight pyrantel (as embonate) corresponding to 14.4 mg/kg pyrantel embonate.

This is equivalent to 1 ml/kg bodyweight.

Through intrauterine (in the womb) and trans-mammary (in the mother's milk) infection, ascarid (roundworm) infestation may occur in dogs at a very early age.
For some animals, especially in case of severe infections, elimination of ascarids may be incomplete, and a potential risk of infections to humans cannot be excluded. Where epidemiologically appropriate, it is recommended that treatment should be started at 2 weeks of age and should be performed repeatedly at suitable intervals (for example every 2 weeks), until weaning.
Otherwise treatment should be based upon confirmed infection, for example the results of faecal examinations.

Method of Administration

Oral administration. The product may be given directly to the animal or mixed with feed. No special dietary measures are necessary.
Mix the product by inversion of the container before drawing the required dose.

Special precautions for use in animals

Do not use simultaneously with piperazine compounds.
Not intended for use in puppies less than 2 weeks of age or weighing less than 0.6kg, as the safety of the product has not been assessed in in this group of animals.
Do not use in pregnant or lactating bitches.

In very rare cases mild transient digestive tract signs (e.g., vomiting diarrhoea) may occur. If you see any adverse signs please notify your veterinary surgeon.

Special precautions to be taken by the person administering the medicinal product to animals

Wash hands after use.
Avoid direct contact with the skin and eyes. In case of accidental spillage wash the affected area immediately with clean running water.

After opening, store the product at a temperature not exceeding 25 ºC

MARKETING AUTHORISATION HOLDER

Bayer plc,
Animal Health Division,
Bayer House,
Strawberry Hill,
Newbury,
Berkshire RG14 1JA

MARKETING AUTHORISATION NUMBER(S)

Vm 00010/4102

Is there any further advice I should know about Drontal?

For more information on Drontal® and Advantage®, and answers to FAQ, see www.drontal.com.